Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Patents
Some Surprises in the European Commission’s New Intellectual Property Strategy
Ellen 't Hoen
-
December 2, 2020
Dutch Court Orders AstraZeneca to Pay Damages in Patent Evergreening Case
Ellen 't Hoen
-
October 14, 2020
TRIPS Council to discuss IP and the public interest in the...
Ellen 't Hoen
-
July 29, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
Never say never – Why the High Income Countries that opted-out...
Christopher Garrison
-
April 8, 2020
Covid-19 and the comeback of compulsory licensing
Ellen 't Hoen
-
March 23, 2020
The Expanding Reach of the European Patent Office. Good for Health?
Ellen 't Hoen
-
March 18, 2020
Uganda tells ARIPO: No more patents for pharmaceuticals
Ellen 't Hoen
-
October 8, 2019
Corbyn’s Compulsory Licenses. Will they work?
Ellen 't Hoen
-
September 26, 2019
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
1
2
Page 1 of 2
This work is licensed under Creative Commons.